GAMMA Investing’s AtriCure ATRC Stock Holding History

GAMMA Investing’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$14.6K	Buy	259 +124	+92%	+$5.59K	﹤0.01%	3141
2026 Q2	$3.78K	Buy	135 +77	+133%	+$2.17K	﹤0.01%	3583
2026 Q1	$1.66K	Sell	58 -93	-62%	-$3.17K	﹤0.01%	3720
2025 Q4	$5.97K	Buy	151 +89	+144%	+$3.26K	﹤0.01%	3206
2025 Q3	$2.19K	Sell	62 -92	-60%	-$3.17K	﹤0.01%	3429
2025 Q2	$5.05K	Buy	154 +42	+38%	+$1.36K	﹤0.01%	3111
2025 Q1	$3.61K	Buy	112 +75	+203%	+$2.78K	﹤0.01%	3215
2024 Q4	$1.13K	Buy	37 +31	+517%	+$997	﹤0.01%	3388
2024 Q3	$168	Sell	6 -3	-33%	-$74	﹤0.01%	3521
2024 Q2	$205	Buy	+9	New	+$208	﹤0.01%	3336

Other funds holding ATRC

MNBTD

Moody National Bank Trust Division Galveston, Texas $1.21B AUM 28.25% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GWM

GK Wealth Management Reno, Nevada $178M AUM 41.48% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

DCM

Davis Capital Management Jacksonville, Florida $167M AUM 17.17% 1-Year Est. Return

GAMMA Investing's ATRC Position: Q3 2026 in Review

GAMMA Investing increased its AtriCure (ATRC) stake by 92% in Q3 2026, buying an estimated $5.59K and bringing the position to 259 shares worth $14.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3141.

GAMMA Investing first reported a position in ATRC in Q2 2024 and has held it in 10 quarters since. 6 funds tracked by Wall St. Rank hold ATRC as of Q3 2026.

GAMMA Investing held 259 shares of AtriCure worth $14.6K as of Q3 2026.
GAMMA Investing bought 124 AtriCure shares in Q3 2026, an estimated $5.59K.
AtriCure made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3141 holding.
GAMMA Investing first reported a position in AtriCure in Q2 2024 and has held it in 10 quarters since.
6 funds tracked by Wall St. Rank held AtriCure as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.